Document Detail


Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?
MedLine Citation:
PMID:  23042939     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective:Whilst cannabis has been associated with an earlier age at onset in schizophrenia, the impact of amphetamine and/or cocaine plus cannabis consumption on age at onset remains unclear. The present study was designed to test the hypothesis that consumption of amphetamine and/or cocaine in addition to cannabis would lead to an earlier age at onset of schizophrenia than that seen for cannabis consumption alone. A secondary objective was to determine what kind of effect additional substance use exerted (e.g. additive, multiplicative).Method:Patients with a diagnosis of schizophrenia were recruited from consecutive admissions to the inpatient and outpatient services of a large psychiatric hospital in Perth, Australia and 167 participants were assessed using the Diagnostic Interview for Psychosis, which included detailed inquiry into illicit drug use in the 12 months prior to the onset of psychiatric symptoms. Participants were categorized into four groups: no illicit substance use (n = 65), cannabis use (n = 68), cannabis plus amphetamine use (n = 25), and cocaine plus cannabis/cocaine plus cannabis plus amphetamine use (n = 9). Analysis of variance was performed to detect trends, and linear regression used to analyze the consumption of each additional substance as a predictor of age at onset.Results:We observed a linear trend for mean age at onset: 23.34 (SD = 6.91) years for no illicit substance use, 22.51 (SD = 5.27) years for cannabis use, 20.84 (SD = 3.48) years for cannabis plus amphetamine use, and 19.56 (SD = 3.54) years for cocaine plus cannabis/cocaine plus cannabis plus amphetamine use; the variation in the means between groups was statistically significant: F(1,163) = 5.66, p = 0.008, Cohen's d = 0.38. For the consumption of each additional substance, age at onset was earlier by 1.2 years: R(2) = 0.034, F(1,165) = 5.72, p = 0.018.Conclusions:Whilst preliminary, these findings suggest that additional consumption of each substance predicted an earlier age at onset by approximately 1 additional year.
Authors:
Brian D Power; Milan Dragovic; Assen Jablensky; Nikos C Stefanis
Related Documents :
24306309 - Ego development in the college years: two longitudinal studies.
23688219 - Does executive control really play a crucial role in explaining age-related cognitive a...
23982439 - Playfulness over the lifespan and its relation to happiness : results from an online su...
24259179 - Evidence for male-produced aggregation pheromone in american palm weevil,rhynchophorus ...
22172859 - Heart transplantation in patients aged 70 years and older: a two-decade experience.
23504299 - Case series on testicular torsion: an educational emergency for sub-saharan africa.
11563609 - Superoxide anion release by peripheral polymorphonuclear leukocytes in welders.
12367569 - Sexual partner preference requires a functional aromatase (cyp19) gene in male mice.
8747239 - 1995 volvo award in clinical sciences. the diagnostic accuracy of magnetic resonance im...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-8
Journal Detail:
Title:  The Australian and New Zealand journal of psychiatry     Volume:  -     ISSN:  1440-1614     ISO Abbreviation:  Aust N Z J Psychiatry     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0111052     Medline TA:  Aust N Z J Psychiatry     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Centre for Clinical Research in Neuropsychiatry, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.
Next Document:  Aquaporin-9 and Urea Transporter-A gene deletions affect urea transmembrane passage in murine hepato...